scholarly article | Q13442814 |
P50 | author | Stella M. Valenzuela | Q40250107 |
Bradley J. Walsh | Q55727469 | ||
Walter D Fairlie | Q57417975 | ||
Kimberley J. Pryor | Q70823146 | ||
P2093 | author name string | X Y He | |
H P Zhang | |||
M Bansal | |||
R C Nicholson | |||
A G Moore | |||
S B Por | |||
S N Breit | |||
J M Robbins | |||
A R Bauskin | |||
M R Bootcov | |||
S Mahler | |||
M Donnellan | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Novel regulators of bone formation: molecular clones and activities | Q24297338 | ||
Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family | Q24298014 | ||
Induction of differentiation of human myeloid leukemias: surface changes probed with monoclonal antibodies | Q70896037 | ||
Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor beta | Q71249157 | ||
An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments | Q71670238 | ||
Characterization of latent TGF-beta activation by murine peritoneal macrophages | Q71961093 | ||
Isolation of human mononuclear cell subsets by counterflow centrifugal elutriation (CCE). I. Characterization of B-lymphocyte-, T-lymphocyte-, and monocyte-enriched fractions by flow cytometric analysis | Q72812075 | ||
Osteogenic protein-2. A new member of the transforming growth factor-beta superfamily expressed early in embryogenesis | Q24299212 | ||
Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells | Q24299727 | ||
Molecular cloning and expression of a chloride ion channel of cell nuclei | Q24318734 | ||
GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons | Q24336322 | ||
Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone | Q24336858 | ||
Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure | Q24562092 | ||
A new type of transforming growth factor-beta, TGF-beta 3 | Q24564095 | ||
Identification of another member of the transforming growth factor type beta gene family | Q24647621 | ||
Structure of two human ovarian inhibins | Q28116517 | ||
Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease | Q28202655 | ||
Transforming growth factor beta in tissue fibrosis | Q28239292 | ||
Evolution of the transforming growth factor-beta superfamily | Q28254597 | ||
GDF-3 and GDF-9: two new members of the transforming growth factor-beta superfamily containing a novel pattern of cysteines | Q28265836 | ||
Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily | Q28284251 | ||
Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells | Q28305879 | ||
Expression and secretion of type beta transforming growth factor by activated human macrophages | Q34341606 | ||
The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms | Q34349039 | ||
Control of transforming growth factor-beta activity: latency vs. activation | Q35241708 | ||
Transforming growth factor beta: the good, the bad, and the ugly | Q36363951 | ||
Human leukemic models of myelomonocytic development: a review of the HL-60 and U937 cell lines. | Q39809041 | ||
Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease | Q40433213 | ||
Tumor necrosis factor: a pleiotropic cytokine and therapeutic target | Q40759728 | ||
Transforming growth factor-beta: latent forms, binding proteins and receptors | Q40851998 | ||
Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta). | Q40883581 | ||
Identification of a novel transforming growth factor-beta (TGF-beta 5) mRNA in Xenopus laevis | Q44023848 | ||
Monocyte proliferation in a cytokine-free, serum-free system | Q44459743 | ||
In vitro replication dynamics of human culture-derived macrophages in a long term serum-free system | Q49157449 | ||
Modulation of cytokine production by transforming growth factor-beta. | Q54351289 | ||
Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. | Q64903823 | ||
Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum | Q68250625 | ||
Complementary deoxyribonucleic acid cloning of a messenger ribonucleic acid encoding transforming growth factor beta 4 from chicken embryo chondrocytes | Q69052012 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Growth differentiation factor 15 | Q74581 |
macrophage | Q184204 | ||
cell-cell signaling | Q14758911 | ||
P304 | page(s) | 11514-11519 | |
P577 | publication date | 1997-10-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily | |
P478 | volume | 94 |
Q38694982 | A GDF15 3' UTR variant, rs1054564, results in allele-specific translational repression of GDF15 by hsa-miR-1233-3p |
Q52599666 | A Meta-Analysis of Genome-Wide Association Studies of Growth Differentiation Factor-15 Concentration in Blood |
Q38855496 | A novel crosstalk between TLR4- and NOD2-mediated signaling in the regulation of intestinal inflammation |
Q38780449 | A novel serum based biomarker panel has complementary ability to preclude presence of early lung cancer for low dose CT (LDCT). |
Q40596797 | A novel time-course cDNA microarray analysis method identifies genes associated with the development of cisplatin resistance |
Q44150669 | A potassium ion channel is involved in cytokine production by activated human macrophages |
Q34055654 | A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. |
Q38859488 | Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review) |
Q24310760 | Activation of p53 by MEG3 non-coding RNA |
Q24321895 | Activin receptor-like kinase 1 is implicated in the maturation phase of angiogenesis |
Q35202902 | Activity of the non-steroidal anti-inflammatory drug indomethacin against colorectal cancer |
Q52768529 | Acute effects of moderate altitude on biomarkers of cardiovascular inflammation and endothelial function and their differential modulation by dual endothelin receptor blockade |
Q30371420 | Acute exacerbations of chronic obstructive pulmonary disease are associated with decreased CD4+ & CD8+ T cells and increased growth & differentiation factor-15 (GDF-15) in peripheral blood. |
Q31120253 | Adaptive Induction of Growth Differentiation Factor 15 Attenuates Endothelial Cell Apoptosis in Response to High Glucose Stimulus |
Q90307443 | Additional Diagnostic Value of Growth Differentiation Factor-15 (GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Different Stages of Heart Failure |
Q37463255 | Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome |
Q64085536 | Age-Associated Changes in the Immune System and Blood⁻Brain Barrier Functions |
Q40449852 | Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53. |
Q33648678 | An autocrine/paracrine circuit of growth differentiation factor (GDF) 15 has a role for maintenance of breast cancer stem-like cells |
Q40420929 | Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays |
Q37327005 | Androgen control of cell proliferation and cytoskeletal reorganization in human fibrosarcoma cells: role of RhoB signaling. |
Q38653870 | Anorexia-cachexia and obesity treatment may be two sides of the same coin: role of the TGF-b superfamily cytokine MIC-1/GDF15. |
Q36421073 | Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15. |
Q40722521 | Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1. |
Q64099112 | Appraising growth differentiation factor 15 as a promising biomarker in digestive system tumors: a meta-analysis |
Q35142408 | Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions. |
Q88976368 | Assessment of the hepatocytic differentiation ability of human skin-derived ABCB5+ stem cells |
Q37252687 | Association and regulation of protein factors of field effect in prostate tissues |
Q39297265 | Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension |
Q37153197 | Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus |
Q92218212 | Association between Growth Differentiation Factor 15 and Non-Dipping Circadian Pattern in Patients with Newly Diagnosed Essential Hypertension |
Q91895922 | Association between MIC-1 and Type 2 Diabetes: A Combined Analysis |
Q47788965 | Association between growth differentiation factor 15 and left ventricular hypertrophy in hypertensive patients and healthy adults |
Q38671285 | Association of Growth Differentiation Factor 15 with Mortality in a Prospective Hemodialysis Cohort |
Q37588805 | Association of Growth Differentiation Factor-15 with Coronary Atherosclerosis and Mortality in a Young, Multiethnic Population: Observations from the Dallas Heart Study |
Q91680464 | Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation |
Q33872067 | Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation. |
Q35634311 | Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma |
Q60044609 | Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease |
Q34170882 | Attenuation of tumor necrosis factor alpha gene transcription in macrophages by an autocrine factor |
Q28216713 | Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells |
Q38073516 | Biomarkers and diagnostics in heart failure |
Q38249997 | Biomarkers in mechanical circulatory support |
Q37678391 | Biomarkers of cardiovascular stress and incident chronic kidney disease |
Q35224090 | Biomarkers of cardiovascular stress and subclinical atherosclerosis in the community |
Q48277775 | Biomechanical stress in myocardial infarctions: can endothelin-1 and growth differentiation factor 15 serve as immunohistochemical markers? |
Q89536574 | Blood Biomarkers of Uveal Melanoma: Current Perspectives |
Q42799481 | Broad up-regulation of innate defense factors during acute cholera |
Q36635956 | COX inhibitors directly alter gene expression: role in cancer prevention? |
Q55486841 | CRP Stimulates GDF15 Expression in Endothelial Cells through p53. |
Q37577453 | Calumenin-15 facilitates filopodia formation by promoting TGF-β superfamily cytokine GDF-15 transcription. |
Q57066901 | Candidate Biomarkers of Liver Fibrosis: A Concise, Pathophysiology-oriented Review |
Q37076096 | Cardiac-Secreted Factors as Peripheral Metabolic Regulators and Potential Disease Biomarkers. |
Q37720494 | Cardiomyocyte-specific transforming growth factor β suppression blocks neutrophil infiltration, augments multiple cytoprotective cascades, and reduces early mortality after myocardial infarction |
Q28081407 | Cardiovascular biomarkers in chronic kidney disease: state of current research and clinical applicability |
Q36351359 | Catalytic Deoxyribozyme-Modified Nanoparticles for RNAi-Independent Gene Regulation |
Q40787504 | Change in gene expression subsequent to induction of Pnn/DRS/memA: increase in p21(cip1/waf1). |
Q35106132 | Change of body weight and macrophage inhibitory cytokine-1 during chemotherapy in advanced gastric cancer: what is their clinical significance? |
Q24554213 | Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury |
Q30793089 | Characterization of the rat, mouse, and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1). |
Q52425192 | Cigarette Smoke Induces Human Airway Epithelial Senescence via Growth Differentiation Factor 15 Production |
Q54542221 | Cigarette smoke induces growth differentiation factor 15 production in human lung epithelial cells: Implication in mucin over-expression |
Q33648690 | Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer |
Q34206335 | Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus |
Q64974281 | Circulating growth/differentiation factor 15 is associated with human CD56bright natural killer cell dysfunction and nosocomial infection in severe systemic inflammation. |
Q91695164 | Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome |
Q39173145 | Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer |
Q34114806 | Clinical and genetic correlates of growth differentiation factor 15 in the community |
Q82909747 | Clinical significance of serum growth differentiation factor-15 levels in systemic sclerosis: association with disease severity |
Q38556589 | Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation |
Q42931044 | Combined detection of serum UL16-binding protein 2 and macrophage inhibitory cytokine-1 improves early diagnosis and prognostic prediction of pancreatic cancer |
Q33205161 | Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray |
Q74387491 | Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study |
Q37344271 | Concise review: growth differentiation factor 15 in pathology: a clinical role? |
Q40299850 | Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways |
Q52562759 | Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer |
Q36578465 | Correlation between growth differentiation factor-15 and collagen metabolism indicators in patients with myocardial infarction and heart failure |
Q52704051 | Correlations of GDF-15 with sST2, MMPs, and worsening functional capacity in idiopathic dilated cardiomyopathy: Can we gain new insights into the pathophysiology? |
Q38670577 | Current and future biomarkers for pancreatic adenocarcinoma |
Q27469850 | DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection |
Q61850122 | Decidual stromal cell-derived PGE2 regulates macrophage responses to microbial threat |
Q41939161 | Deficiency of liver sinusoidal scavenger receptors stabilin-1 and -2 in mice causes glomerulofibrotic nephropathy via impaired hepatic clearance of noxious blood factors. |
Q36779000 | Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study |
Q47168309 | Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer |
Q44970452 | Diagnostic Validity of Serum Macrophage Inhibitor Cytokine and Tissue Polypeptide-Specific Antigen in Pancreatobiliary Diseases |
Q37284685 | Diagnostic and prognostic biomarkers in pancreatic carcinoma |
Q36094396 | Differentiated embryo-chondrocyte expressed gene 1 regulates p53-dependent cell survival versus cell death through macrophage inhibitory cytokine-1 |
Q24801085 | Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs |
Q34099900 | Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer |
Q47893482 | Dysregulated expression of MIC-1/PDF in human prostate tumor cells |
Q38412532 | Early Epithelial Restitution by Nonsteroidal Anti-Inflammatory Drug-Activated Gene 1 Counteracts Intestinal Ulcerative Injuries |
Q36621007 | Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia. |
Q34077759 | Effect of Protein Kinase C delta (PKC-δ) Inhibition on the Transcriptome of Normal and Systemic Sclerosis Human Dermal Fibroblasts In Vitro |
Q53244256 | Effect of the Phytotherapeutic Agent Eviprostat on Inflammatory Changes and Cytokine Production in a Rat Model of Nonbacterial Prostatitis |
Q61780886 | Effects of An E-cadherin-Derived Peptide on the Gene Expression of Caco-2 Cells |
Q47985560 | Elevated GDF-15 contributes to pulmonary inflammation upon cigarette smoke exposure. |
Q84204747 | Elevated Plasma Growth Differentiation Factor-15 Correlates with Lymph Node Metastases and Poor Survival in Endometrial Cancer |
Q61449764 | Elevated Serum Growth Differentiation Factor 15 Levels in Hyperthyroid Patients |
Q41093240 | Elevated serum growth differentiation factor 15 levels are associated with thyroid nodules in type 2 diabetes aged over 60 years |
Q58593625 | Elucidating the role of Agl in bladder carcinogenesis by generation and characterization of genetically engineered mice |
Q38452303 | Enteropathogenic Escherichia coli-induced macrophage inhibitory cytokine 1 mediates cancer cell survival: an in vitro implication of infection-linked tumor dissemination |
Q44777390 | Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause |
Q89529374 | Estradiol-17β-Induced Changes in the Porcine Endometrial Transcriptome In Vivo |
Q26827810 | Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. |
Q38271582 | Evolutionary roots of arginase expression and regulation |
Q49339915 | Exercise increases circulating GDF15 in humans. |
Q28552243 | Expression of Human NSAID Activated Gene 1 in Mice Leads to Altered Mammary Gland Differentiation and Impaired Lactation |
Q38347071 | Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. |
Q39270428 | Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression |
Q74273264 | Expression of a TGF-beta superfamily protein, macrophage inhibitory cytokine-1, in the yeast Pichia pastoris |
Q34093137 | Expression of growth differentiation factor-15/ macrophage inhibitory cytokine-1 (GDF-15/MIC-1) in the perinatal, adult, and injured rat brain |
Q24300247 | Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells |
Q34600781 | Expression profiling of PC-3 cell line variants and comparison of MIC-1 transcript levels in benign and malignant prostate |
Q38104878 | Fetomaternal immune cross-talk and its consequences for maternal and offspring's health |
Q37239667 | GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance. |
Q26798142 | GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective |
Q92973308 | GDF-15 in solid vs non-solid treatment-naïve malignancies |
Q58807888 | GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice |
Q50985503 | GDF-15 is increased during early reperfusion following aortic valve replacement |
Q38647581 | GDF-15 predicts cardiovascular events in acute chest pain patients. |
Q36982817 | GDF-15 protects from macrophage accumulation in a mousemodel of advanced atherosclerosis |
Q33362887 | GDF-15, iron, and inflammation in early chronic kidney disease among elderly patients |
Q34007029 | GDF-15: a novel serum marker for metastases in uveal melanoma patients. |
Q92103003 | GDF15 Is Elevated in Conditions of Glucocorticoid Deficiency and Is Modulated by Glucocorticoid Replacement |
Q34750077 | GDF15 Is a Novel Biomarker for Impaired Fasting Glucose |
Q64061570 | GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans |
Q59807334 | GDF15 and Growth Control |
Q49557783 | GDF15 and energy balance: homing in on a mechanism. |
Q38904689 | GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways. |
Q91440486 | GDF15 induced by compressive force contributes to osteoclast differentiation in human periodontal ligament cells |
Q41198863 | GDF15 is a heart-derived hormone that regulates body growth |
Q33631141 | GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients |
Q92451809 | GDF15 mediates adiposity resistance through actions on GFRAL neurons in the hindbrain AP/NTS |
Q52630342 | GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer. |
Q36729546 | GDF15 promotes EMT and metastasis in colorectal cancer |
Q64058641 | GDF15 secreted by senescent endothelial cells improves vascular progenitor cell functions |
Q36906059 | GDF15 triggers homeostatic proliferation of acid-secreting collecting duct cells |
Q28550541 | GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson's Disease and Lewy Body Dementia |
Q47897710 | GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand |
Q48793100 | Gdf-15 deficiency does not alter vulnerability of nigrostriatal dopaminergic system in MPTP-intoxicated mice |
Q38453453 | Genome-wide DNA methylation study identifies genes associated with the cardiovascular biomarker GDF-15 |
Q39332689 | Genomic organization and modulation of gene expression of the TGF-β and FGF pathways in the allotetraploid frog Xenopus laevis |
Q34992518 | Glioma cancer stem cells induce immunosuppressive macrophages/microglia |
Q99724619 | Growth Differentiation Factor 15 Ameliorates Anti-Glomerular Basement Membrane Glomerulonephritis in Mice |
Q35778076 | Growth Differentiation Factor 15 Expression in Astrocytes After Excitotoxic Lesion in the Mouse Hippocampus |
Q33916208 | Growth Differentiation Factor 15 Is Induced by Hepatitis C Virus Infection and Regulates Hepatocellular Carcinoma-Related Genes |
Q57465073 | Growth Differentiation Factor 15 Maturation Requires Proteolytic Cleavage by PCSK3, -5, and -6 |
Q41180466 | Growth Differentiation Factor 15 May Predict Mortality of Peripheral and Coronary Artery Diseases and Correlate with Their Risk Factors |
Q89848874 | Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation |
Q38041973 | Growth Differentiation Factor 15 in Heart Failure: An Update |
Q90460790 | Growth Differentiation Factor-15 (GDF-15) is a Biomarker of Muscle Wasting and Renal Dysfunction in Preoperative Cardiovascular Surgery Patients |
Q33682931 | Growth Differentiation Factor-15 Deficiency Augments Inflammatory Response and Exacerbates Septic Heart and Renal Injury Induced by Lipopolysaccharide |
Q87015006 | Growth Differentiation Factor-15 Is a Novel Biomarker Predicting Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
Q47213170 | Growth Differentiation Factor-15 Is a Predictor of Mortality in Critically Ill Patients with Sepsis. |
Q64945080 | Growth Differentiation Factor-15 Levels at Admission Provide Incremental Prognostic Information on All-Cause Long-term Mortality in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. |
Q37494863 | Growth Differentiation Factor-15-Induced Contractile Activity and Extracellular Matrix Production in Human Trabecular Meshwork Cells |
Q41831221 | Growth Differentiation Factor‐15 Deficiency Inhibits Atherosclerosis Progression by Regulating Interleukin‐6–Dependent Inflammatory Response to Vascular Injury |
Q37535244 | Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells. |
Q37683299 | Growth differentiation factor (GDF)-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of epidermal growth factor receptor transactivation |
Q47368220 | Growth differentiation factor (GDF-15) concentration combined with Ca125 levels in serum is superior to commonly used cancer biomarkers in differentiation of pancreatic mass |
Q35316842 | Growth differentiation factor 15 (GDF15)-mediated HER2 phosphorylation reduces trastuzumab sensitivity of HER2-overexpressing breast cancer cells |
Q88537974 | Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice |
Q48132987 | Growth differentiation factor 15 as a predictor of adverse renal outcomes in patients with immunoglobulin A nephropathy. |
Q38886357 | Growth differentiation factor 15 as a radiation-induced marker in oral carcinoma increasing radiation resistance |
Q44871151 | Growth differentiation factor 15 can distinguish between hypertrophic cardiomyopathy and hypertensive hearts |
Q42288906 | Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis |
Q92036930 | Growth differentiation factor 15 facilitates lung fibrosis by activating macrophages and fibroblasts |
Q52632771 | Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium |
Q88530129 | Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact |
Q95338257 | Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player |
Q37896086 | Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside |
Q85066486 | Growth differentiation factor 15 in different stages of heart failure: potential screening implications |
Q33908936 | Growth differentiation factor 15 in erythroid health and disease |
Q54623631 | Growth differentiation factor 15 in multiple myeloma: a microenvironment factor predictive of response to treatment? |
Q37576614 | Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis. |
Q37117179 | Growth differentiation factor 15 is a promising diagnostic and prognostic biomarker in colorectal cancer |
Q48176713 | Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. |
Q57802372 | Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer-Cardiovascular Cohort |
Q47121253 | Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling |
Q49089937 | Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development |
Q42541470 | Growth differentiation factor 15: a canary in a coal mine? |
Q36997947 | Growth differentiation factor-15 and prognosis in acute respiratory distress syndrome: a retrospective cohort study |
Q91274465 | Growth differentiation factor-15 and the risk of cardiovascular diseases and all-cause mortality: A meta-analysis of prospective studies |
Q37726734 | Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia |
Q84472567 | Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer |
Q90369225 | Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study |
Q36040617 | Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death. |
Q53436137 | Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. |
Q44226730 | Growth differentiation factor-15 in idiopathic pulmonary arterial hypertension |
Q94502868 | Growth differentiation factor-15 is a prognostic marker in patients with intermediate coronary artery disease |
Q36893044 | Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo. |
Q37420336 | Growth differentiation factor-15 predicts mortality and morbidity after cardiac resynchronization therapy |
Q44270136 | Growth differentiation factor-15 prevents low potassium-induced cell death of cerebellar granule neurons by differential regulation of Akt and ERK pathways |
Q39917432 | Growth differentiation factor-15: a new biomarker in cardiovascular disease |
Q39218029 | Growth differentiation factor‐15 (GDF‐15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2) |
Q35021094 | Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study |
Q39967372 | Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study |
Q57248441 | Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo |
Q37988746 | Growth/differentiation factor-15: prostate cancer suppressor or promoter? |
Q38100647 | Heart Failure Biomarkers |
Q34008796 | Hepcidin levels and their determinants in different types of myelodysplastic syndromes |
Q39279337 | Histamine receptor 2-mediated growth-differentiation factor-15 expression is involved in histamine-induced melanogenesis |
Q39947180 | Human cell toxicogenomic analysis of bromoacetic acid: a regulated drinking water disinfection by-product |
Q51372416 | Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity. |
Q34032238 | Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome |
Q31163927 | Identification of placental transforming growth factor-beta and bikunin metabolites as contaminants of pharmaceutical human chorionic gonadotrophin preparations by proteomic techniques. |
Q34005039 | Identification of tgh-2, a filarial nematode homolog of Caenorhabditis elegans daf-7 and human transforming growth factor beta, expressed in microfilarial and adult stages of Brugia malayi |
Q36328508 | Identifying molecular markers for the early detection of pancreatic neoplasia |
Q34676437 | Immune therapeutic targeting of glioma cancer stem cells |
Q35967042 | Immunological aspects of head and neck cancer: biology, pathophysiology and therapeutic mechanisms. |
Q37383991 | Immunomodulation by mucosal gene transfer using TGF-beta DNA |
Q37939411 | Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. |
Q34923343 | Increased Expression of Growth Differentiation Factor-15 in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension |
Q44638845 | Induction of MIC-1/growth differentiation factor-15 following bile duct injury |
Q34988108 | Induction of the unfolded protein response drives enhanced metabolism and chemoresistance in glioma cells |
Q28083759 | Inflammation induced loss of skeletal muscle |
Q36076068 | Inflammation-associated regulation of the macrophage inhibitory cytokine (MIC-1) gene in prostate cancer |
Q46311360 | Influence of inflammation and aging on macrophage inhibitory cytokine-1 gene expression in rat ventral prostate |
Q60920838 | Inhibition of Breast Cancer Cell Invasion by Ras Suppressor-1 (RSU-1) Silencing Is Reversed by Growth Differentiation Factor-15 (GDF-15) |
Q36615163 | Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk |
Q33728115 | Intertwining Threshold Settings, Biological Data and Database Knowledge to Optimize the Selection of Differentially Expressed Genes from Microarray |
Q41852225 | Is GDF15 a Novel Biomarker to Predict the Development of Prediabetes or Diabetes? |
Q30452357 | Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum |
Q37958714 | Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation |
Q60062002 | Local bioactive tumour necrosis factor (TNF) in corneal allotransplantation |
Q47608130 | Long-acting MIC-1/GDF15 molecules to treat obesity: Evidence from mice to monkeys. |
Q35475302 | MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma |
Q34045939 | Macrophage inhibitory cytokine 1 (MIC-1/GDF15) as a novel diagnostic serum biomarker in pancreatic ductal adenocarcinoma |
Q28730588 | Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets |
Q35133770 | Macrophage inhibitory cytokine 1 mediates a p53-dependent protective arrest in S phase in response to starvation for DNA precursors |
Q39870198 | Macrophage inhibitory cytokine MIC-1 is upregulated by short-wavelength light in cultured normal human dermal fibroblasts |
Q35563909 | Macrophage inhibitory cytokine-1 (MIC-1/GDF15) gene deletion promotes cancer growth in TRAMP prostate cancer prone mice |
Q34405669 | Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice |
Q40015389 | Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. |
Q33882542 | Macrophage inhibitory cytokine-1 regulates melanoma vascular development |
Q54944542 | Macrophage inhibitory cytokine-1 versus carbohydrate antigen 19-9 as a biomarker for diagnosis of pancreatic cancer: A PRISMA-compliant meta-analysis of diagnostic accuracy studies. |
Q93197174 | Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort |
Q37369895 | Macrophage inhibitory cytokine-1: a new player in melanoma development |
Q35051499 | Macrophage inhibitory factor 1 acts as a potential biomarker in patients with esophageal squamous cell carcinoma and is a target for antibody-based therapy |
Q34793000 | Maternal Serum Macrophage Inhibitory Cytokine-1 as a Biomarker for Ectopic Pregnancy in Women with a Pregnancy of Unknown Location |
Q92509452 | Mechanically-induced GDF15 Secretion by Periodontal Ligament Fibroblasts Regulates Osteogenic Transcription |
Q41197754 | Members of the heat-shock protein 70 family promote cancer cell growth by distinct mechanisms |
Q93192737 | Metabolic remodeling induced by mitokines in heart failure |
Q38351948 | Microarray analysis uncovers retinoid targets in human bronchial epithelial cells |
Q34700334 | Microarray and Pathway Analysis Reveal Distinct Mechanisms Underlying Cannabinoid-Mediated Modulation of LPS-Induced Activation of BV-2 Microglial Cells |
Q36440214 | Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast Cancer |
Q36499656 | Molecular characterisation of canine nonsteroidal anti-inflammatory drug-activated gene (NAG-1). |
Q42507061 | Molecular cloning and characterization of human nonsteroidal anti-inflammatory drug-activated gene promoter. Basal transcription is mediated by Sp1 and Sp3. |
Q91410942 | Molecular pathways linking adipose innervation to insulin action in obesity and diabetes mellitus |
Q28192995 | Molecular targets of dietary polyphenols with anti-inflammatory properties |
Q38956732 | Monocyte chemotactic protein-1 (MCP-1/CCL2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia |
Q54917685 | Moonlighting Activity of Secreted Inflammation-Regulatory Proteins. |
Q38616107 | Moonlighting proteins in cancer. |
Q35821663 | Morphological effects on expression of growth differentiation factor 15 (GDF15), a marker of metastasis. |
Q48165741 | Multibiomarker analysis in patients with acute myocardial infarction |
Q38679160 | Multiple TGF-β superfamily signals modulate the adult Drosophila immune response |
Q89567501 | Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress |
Q36739054 | Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma |
Q34054078 | NAG-1/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism |
Q28114786 | NAG-1/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway |
Q36869509 | NAG-1/GDF15 transgenic mouse has less white adipose tissue and a reduced inflammatory response |
Q47155954 | NF-κB regulates GDF-15 to suppress macrophage surveillance during early tumor development. |
Q39628874 | NSAID inhibition of prostate cancer cell migration is mediated by Nag-1 Induction via the p38 MAPK-p75(NTR) pathway |
Q36625481 | Neutrophil gelatinase-associated lipocalin, macrophage inhibitory cytokine 1, and carbohydrate antigen 19-9 in pancreatic juice: pathobiologic implications in diagnosing benign and malignant disease of the pancreas |
Q93108422 | New Cardiovascular Biomarkers in Ischemic Heart Disease-GDF-15, A Probable Predictor for Ejection Fraction |
Q37230433 | Nonsteroidal anti-inflammatory drug-activated gene-1 expression inhibits urethane-induced pulmonary tumorigenesis in transgenic mice |
Q28596829 | Novel biomarkers for risk stratification in pulmonary arterial hypertension |
Q37997237 | Novel biomarkers in chronic heart failure |
Q37894731 | Novel biomarkers in human terminal heart failure and under mechanical circulatory support |
Q38262569 | Novel serum biomarkers in pulmonary arterial hypertension |
Q28538175 | Opposing effects of PI3K/Akt and Smad-dependent signaling pathways in NAG-1-induced glioblastoma cell apoptosis |
Q41055826 | Over-expression of growth differentiation factor 15 (GDF15) preventing cold ischemia reperfusion (I/R) injury in heart transplantation through Foxo3a signaling. |
Q45323971 | Over-production of growth differentiation factor 15 (GDF15) promotes human rhinovirus infection and virus-induced inflammation in the lung. |
Q24620497 | Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway |
Q34675545 | P38 MAPK contributes to resistance and invasiveness of HER2- overexpressing breast cancer |
Q37143062 | PTGF-beta, a type beta transforming growth factor (TGF-beta) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway |
Q43411896 | Panel of emerging cardiac biomarkers contributes for prognosis rather than diagnosis in chronic heart failure |
Q58705640 | Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches |
Q73969504 | Placental bone morphogenetic protein (PLAB) gene expression in normal, pre-malignant and malignant human prostate: relation to tumor development and progression |
Q53728725 | Plasma Growth Differentiation Factor-15 is a Potential Biomarker for Pediatric Pulmonary Arterial Hypertension Associated with Congenital Heart Disease |
Q36446724 | Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women |
Q33723662 | Plasma MIC-1 correlates with systemic inflammation but is not an independent determinant of nutritional status or survival in oesophago-gastric cancer |
Q38658656 | Plasma cytokines can help to identify the development of severe acute pancreatitis on admission |
Q37605661 | Plasma growth differentiation factor 15 predicts first-ever stroke in hypertensive patients |
Q104681912 | Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis |
Q33932770 | Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy |
Q61817355 | Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer |
Q37014872 | Plasma levels of growth differentiation factor-15 are associated with myocardial injury in patients undergoing off-pump coronary artery bypass grafting |
Q33204505 | Plasticity of mouse renal collecting duct in response to potassium depletion |
Q37155198 | Potential Markers in Cardiac Hypertrophy? |
Q34577084 | Potentials of Plasma NGAL and MIC-1 as Biomarker(s) in the Diagnosis of Lethal Pancreatic Cancer |
Q55149583 | Predictive value of long-term changes of growth differentiation factor-15 over a 27-year-period for heart failure and death due to coronary heart disease. |
Q56524569 | Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes |
Q40893077 | Profile of gene expression regulated by induced p53: connection to the TGF-beta family |
Q89397554 | Progress in heart failure treatment in Germany |
Q35872640 | Progressive postnatal motoneuron loss in mice lacking GDF-15. |
Q36911360 | Prolonged NF-κB Activation by a Macrophage Inhibitory Cytokine 1-Linked Signal in Enteropathogenic Escherichia coli-Infected Epithelial Cells |
Q38019709 | Promiscuity and specificity in BMP receptor activation |
Q42435517 | Proprotein convertases regulate activity of prostate epithelial cell differentiation markers and are modulated in human prostate cancer cells |
Q33642321 | Prostate cancer and inflammation: the evidence |
Q37087947 | Prostate cancer: genes, environment, immunity and the use of immunotherapy |
Q35175108 | Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue |
Q56501853 | Protection against L3 induced Brugia malayi infection in Mastomys coucha pre-immunized with BmAFII fraction of the filarial adult worm |
Q40448446 | Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. |
Q90974990 | Proteome and Secretome Dynamics of Human Retinal Pigment Epithelium in Response to Reactive Oxygen Species |
Q36646676 | Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues |
Q39128591 | RNPC1, an RNA-binding Protein and a p53 Target, Regulates Macrophage Inhibitory Cytokine-1 (MIC-1) Expression through mRNA Stability |
Q35675385 | Reconstitution of TGFBR2-Mediated Signaling Causes Upregulation of GDF-15 in HCT116 Colorectal Cancer Cells |
Q43125020 | Reduced expression of GDF-15 is associated with atrophic inflammatory lesions of the prostate |
Q53693528 | Reduced oxidative capacity in macrophages results in systemic insulin resistance. |
Q42587600 | Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemia |
Q46220255 | Regulation of growth differentiation factor 15 expression by intracellular iron. |
Q102388807 | Relationship between plasma growth differentiation factor-15 levels and diabetic retinopathy in individuals with type 2 diabetes |
Q92714868 | Relationship of growth differentiation factor-15 with aortic stiffness in essential hypertension |
Q47129121 | Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
Q89601774 | Renoprotective and Immunomodulatory Effects of GDF15 following AKI Invoked by Ischemia-Reperfusion Injury |
Q37411797 | Review paper: Cancer chemopreventive compounds and canine cancer. |
Q38019013 | Role of Urokinase Plasminogen Activator Receptor in Gastric Cancer: A Potential Therapeutic Target |
Q40581135 | Role of viral vectors and virion shells in cellular gene expression |
Q92741974 | Roles of Growth Differentiation Factor 15 in Atherosclerosis and Coronary Artery Disease |
Q39381230 | Rottlerin induces apoptosis of HT29 colon carcinoma cells through NAG-1 upregulation via an ERK and p38 MAPK-dependent and PKC δ-independent mechanism |
Q38790569 | Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders |
Q38909951 | Selective cathepsin S inhibition attenuates atherosclerosis in apolipoprotein E-deficient mice with chronic renal disease |
Q92467866 | Senescence-associated tissue microenvironment promotes colon cancer formation through the secretory factor GDF15 |
Q52868225 | Serum GDF-15 level in Behçet's disease: relationships between disease activity and clinical parameters |
Q35711126 | Serum Levels of Human MIC-1/GDF15 Vary in a Diurnal Pattern, Do Not Display a Profile Suggestive of a Satiety Factor and Are Related to BMI. |
Q61843304 | Serum concentrations of macrophage inhibitory cytokine 1 (MIC 1) as a predictor of miscarriage |
Q38166573 | Serum tumor markers in pancreatic cancer-recent discoveries |
Q41002538 | Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer |
Q50054012 | Statin Effects on Myocardial Fibrosis Markers in People Living with HIV. |
Q92220231 | Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders |
Q24564006 | Strategies for early detection of resectable pancreatic cancer |
Q39783969 | Study of the association between growth differentiation factor 15 gene polymorphism and coronary artery disease in a Chinese population |
Q64767710 | Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture |
Q28505375 | Suppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutant |
Q53540200 | TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation |
Q36647686 | TGF-b superfamily cytokine MIC-1/GDF15 is a physiological appetite and body weight regulator |
Q34470060 | TGF-beta and the regulation of neuron survival and death. |
Q28481232 | Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer |
Q58942288 | Targeting the Cellular “Oxygen Sensors”: Hypoxia Pre-Conditioning and Stabilization of Hypoxia-Inducible Factors |
Q50026527 | The ABC death risk score: is it time to start measuring GDF-15? |
Q34447208 | The Association of Growth Differentiation Factor-15 with Left Ventricular Hypertrophy in Hypertensive Patients |
Q58788261 | The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome |
Q37228840 | The RNA-binding protein TTP is a global post-transcriptional regulator of feedback control in inflammation |
Q37673210 | The Role of NAG-1/GDF15 in the Inhibition of Intestinal Polyps in APC/Min Mice by Sulindac |
Q33817236 | The anorectic actions of the TGFβ cytokine MIC-1/GDF15 require an intact brainstem area postrema and nucleus of the solitary tract |
Q90718919 | The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes |
Q36039060 | The catalytic efficiency of yeast ribonuclease III depends on substrate specific product release rate |
Q35620885 | The correlation of serum growth differentiation factor-15 level in patients with obstructive sleep apnea |
Q98157894 | The cytokine GDF15 signals through a population of brainstem cholecystokinin neurons to mediate anorectic signalling |
Q35652985 | The development of gene therapy for diseases of the lung |
Q38358925 | The divergent roles of growth differentiation factor-15 (GDF-15) in benign and malignant skin pathologies |
Q36592451 | The diverse roles of nonsteroidal anti-inflammatory drug activated gene (NAG-1/GDF15) in cancer |
Q34277115 | The effect of full length and mature NAG-1 protein overexpression on cytotoxicity of celecoxib, tamoxifen and doxorubicin in HT1080 |
Q38605925 | The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. |
Q38115886 | The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1 |
Q40749068 | The propeptide of macrophage inhibitory cytokine (MIC-1), a TGF-beta superfamily member, acts as a quality control determinant for correctly folded MIC-1. |
Q73693575 | The propeptide of the transforming growth factor-beta superfamily member, macrophage inhibitory cytokine-1 (MIC-1), is a multifunctional domain that can facilitate protein folding and secretion |
Q35388790 | The relationship of serum macrophage inhibitory cytokine-1 levels with gray matter volumes in community-dwelling older individuals. |
Q36201496 | The role of growth differentiation factor 15 in the pathogenesis of primary myelofibrosis |
Q38211077 | The role of inflammation in prostate cancer |
Q40667908 | The transcriptional response after oxidative stress is defective in Cockayne syndrome group B cells |
Q94672733 | Therapeutic effect of psoralen on muscle atrophy induced by tumor necrosis factor-α |
Q38335010 | Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. |
Q28482454 | Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: involvement of NAG-1 expression |
Q64903654 | Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15. |
Q103044420 | Transcriptome analysis of pig macrophages expressing porcine reproductive and respiratory syndrome virus non-structural protein 1 |
Q40956039 | Transforming growth factor-beta1, a strong costimulator of rat T-cell activation promoting a shift towards a Th2-like cytokine profile |
Q33779887 | Tumor Necrosis Factor Alpha Transcription in Macrophages Is Attenuated by an Autocrine Factor That Preferentially Induces NF-κB p50 |
Q40056643 | Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1. |
Q34493884 | Ultraviolet B-induced expression of amphiregulin and growth differentiation factor 15 in human lens epithelial cells. |
Q60931608 | Utility of GDF-15 as a diagnostic biomarker in gastric cancer: an investigation combining GEO, TCGA and meta-analysis |
Q37388415 | Variations in NAG-1 expression of human gastric carcinoma and normal gastric tissues |
Q92092600 | [GDF-15 in plasma and circulating mononuclear cells and NT-proBNP for diagnosis of chronic heart failure and predicting cardiovascular disease events] |
Search more.